Annual Cash & Cash Equivalents
$4.31 M
+$673.00 K+18.52%
December 31, 2023
Summary
- As of February 7, 2025, NEPH annual cash & cash equivalents is $4.31 million, with the most recent change of +$673.00 thousand (+18.52%) on December 31, 2023.
- During the last 3 years, NEPH annual cash & cash equivalents has fallen by -$3.94 million (-47.79%).
- NEPH annual cash & cash equivalents is now -47.79% below its all-time high of $8.25 million, reached on December 31, 2020.
Performance
NEPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.46 M
-$623.00 K-20.23%
September 1, 2024
Summary
- As of February 7, 2025, NEPH quarterly cash and cash equivalents is $2.46 million, with the most recent change of -$623.00 thousand (-20.23%) on September 1, 2024.
- Over the past year, NEPH quarterly cash and cash equivalents has dropped by -$1.85 million (-42.95%).
- NEPH quarterly cash and cash equivalents is now -73.97% below its all-time high of $9.44 million, reached on September 30, 2004.
Performance
NEPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NEPH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.5% | -43.0% |
| 3 y3 years | -47.8% | -43.0% |
| 5 y5 years | -6.0% | -43.0% |
NEPH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.2% | +18.5% | -64.8% | at low |
| 5 y | 5-year | -47.8% | +18.5% | -72.6% | at low |
| alltime | all time | -47.8% | +9063.8% | -74.0% | +5127.7% |
Nephros Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.46 M(-20.2%) |
| Jun 2024 | - | $3.08 M(-15.2%) |
| Mar 2024 | - | $3.63 M(-15.6%) |
| Dec 2023 | $4.31 M(+18.5%) | $4.31 M(-6.8%) |
| Sep 2023 | - | $4.62 M(+13.8%) |
| Jun 2023 | - | $4.06 M(+5.8%) |
| Mar 2023 | - | $3.84 M(+5.6%) |
| Dec 2022 | $3.63 M(-47.9%) | $3.63 M(-7.8%) |
| Sep 2022 | - | $3.94 M(-5.7%) |
| Jun 2022 | - | $4.18 M(-22.9%) |
| Mar 2022 | - | $5.42 M(-22.3%) |
| Dec 2021 | $6.97 M(-15.5%) | $6.97 M(-5.1%) |
| Sep 2021 | - | $7.35 M(-11.2%) |
| Jun 2021 | - | $8.28 M(+1.4%) |
| Mar 2021 | - | $8.16 M(-1.0%) |
| Dec 2020 | $8.25 M(+98.0%) | $8.25 M(+60.0%) |
| Sep 2020 | - | $5.16 M(-26.8%) |
| Jun 2020 | - | $7.05 M(-21.4%) |
| Mar 2020 | - | $8.96 M(+115.1%) |
| Dec 2019 | $4.17 M(-9.1%) | $4.17 M(+8.1%) |
| Sep 2019 | - | $3.85 M(-10.7%) |
| Jun 2019 | - | $4.32 M(+19.7%) |
| Mar 2019 | - | $3.61 M(-21.2%) |
| Dec 2018 | $4.58 M(+108.8%) | $4.58 M(-13.9%) |
| Sep 2018 | - | $5.32 M(+52.8%) |
| Jun 2018 | - | $3.48 M(+91.5%) |
| Mar 2018 | - | $1.82 M(-17.1%) |
| Dec 2017 | $2.19 M(+697.8%) | $2.19 M(+1362.7%) |
| Sep 2017 | - | $150.00 K(-50.2%) |
| Jun 2017 | - | $301.00 K(-62.5%) |
| Mar 2017 | - | $803.00 K(+192.0%) |
| Dec 2016 | $275.00 K(-78.0%) | $275.00 K(-65.9%) |
| Sep 2016 | - | $807.00 K(-49.6%) |
| Jun 2016 | - | $1.60 M(+128.5%) |
| Mar 2016 | - | $701.00 K(-43.8%) |
| Dec 2015 | $1.25 M(-2.8%) | $1.25 M(-31.2%) |
| Sep 2015 | - | $1.81 M(+74.8%) |
| Jun 2015 | - | $1.04 M(+182.6%) |
| Mar 2015 | - | $367.00 K(-71.4%) |
| Dec 2014 | $1.28 M | $1.28 M(+22.6%) |
| Sep 2014 | - | $1.05 M(+365.3%) |
| Jun 2014 | - | $225.00 K(-52.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $473.00 K(-18.3%) |
| Dec 2013 | $579.00 K(+1131.9%) | $579.00 K(+244.6%) |
| Sep 2013 | - | $168.00 K(-43.6%) |
| Jun 2013 | - | $298.00 K(+22.6%) |
| Mar 2013 | - | $243.00 K(+417.0%) |
| Dec 2012 | $47.00 K(-97.2%) | $47.00 K(-87.2%) |
| Sep 2012 | - | $366.00 K(-62.9%) |
| Jun 2012 | - | $987.00 K(-54.6%) |
| Mar 2012 | - | $2.17 M(+30.3%) |
| Dec 2011 | $1.67 M(+595.4%) | $1.67 M(-21.2%) |
| Sep 2011 | - | $2.12 M(+23.6%) |
| Jun 2011 | - | $1.71 M(-23.8%) |
| Mar 2011 | - | $2.25 M(+836.3%) |
| Dec 2010 | $240.00 K(-76.1%) | $240.00 K(-43.0%) |
| Sep 2010 | - | $421.00 K(+22.4%) |
| Jun 2010 | - | $344.00 K(-39.0%) |
| Mar 2010 | - | $564.00 K(-43.8%) |
| Dec 2009 | $1.00 M(-56.5%) | $1.00 M(-44.1%) |
| Sep 2009 | - | $1.79 M(+101.7%) |
| Jun 2009 | - | $890.00 K(-46.1%) |
| Mar 2009 | - | $1.65 M(-28.4%) |
| Dec 2008 | $2.31 M(-33.1%) | $2.31 M(-38.4%) |
| Sep 2008 | - | $3.75 M(+166.7%) |
| Jun 2008 | - | $1.40 M(-44.0%) |
| Mar 2008 | - | $2.50 M(-27.4%) |
| Dec 2007 | $3.45 M(+1263.2%) | $3.45 M(-47.0%) |
| Sep 2007 | - | $6.51 M(+1128.9%) |
| Jun 2007 | - | $530.00 K(+28.3%) |
| Mar 2007 | - | $413.00 K(+63.2%) |
| Dec 2006 | $253.00 K(-66.1%) | $253.00 K(-72.6%) |
| Sep 2006 | - | $924.00 K(-45.3%) |
| Jun 2006 | - | $1.69 M(+3201.8%) |
| Mar 2006 | - | $51.20 K(-93.1%) |
| Dec 2005 | $746.60 K(-79.9%) | $746.60 K(-9.9%) |
| Sep 2005 | - | $828.90 K(-70.6%) |
| Jun 2005 | - | $2.82 M(-34.7%) |
| Mar 2005 | - | $4.32 M(+16.0%) |
| Dec 2004 | $3.72 M(-9.8%) | $3.72 M(-60.6%) |
| Sep 2004 | - | $9.44 M(+155.3%) |
| Jun 2004 | - | $3.70 M |
| Dec 2003 | $4.12 M(+1614.4%) | - |
| Dec 2002 | $240.40 K | - |
FAQ
- What is Nephros annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Nephros?
- What is Nephros annual cash & cash equivalents year-on-year change?
- What is Nephros quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Nephros?
- What is Nephros quarterly cash and cash equivalents year-on-year change?
What is Nephros annual cash & cash equivalents?
The current annual cash & cash equivalents of NEPH is $4.31 M
What is the all time high annual cash & cash equivalents for Nephros?
Nephros all-time high annual cash & cash equivalents is $8.25 M
What is Nephros annual cash & cash equivalents year-on-year change?
Over the past year, NEPH annual cash & cash equivalents has changed by +$673.00 K (+18.52%)
What is Nephros quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NEPH is $2.46 M
What is the all time high quarterly cash and cash equivalents for Nephros?
Nephros all-time high quarterly cash and cash equivalents is $9.44 M
What is Nephros quarterly cash and cash equivalents year-on-year change?
Over the past year, NEPH quarterly cash and cash equivalents has changed by -$1.85 M (-42.95%)